[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::811036897883492352.png) @BiopharmIQ BiopharmIQ by Amp

GSK's Blenrep (belantamab mafodotin) is under FDA review, with an advisory committee meeting recently discussing its use in combination with other treatments for multiple myeloma. The FDA raised safety concerns, including high rates of ocular toxicity. A decision on the treatment's approval is expected soon.

### Engagements: XXXXXX [#](/creator/twitter::811036897883492352/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::811036897883492352/c:line/m:interactions.svg)

- X Week XXXXXXX +49%
- X Month XXXXXXX +22%
- X Months XXXXXXXXX -XXXX%
- X Year XXXXXXXXX -XX%

### Mentions: XX [#](/creator/twitter::811036897883492352/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::811036897883492352/c:line/m:posts_active.svg)

- X Week XX +16%
- X Month XXX +29%
- X Months XXX -XX%
- X Year XXXXX +38%

### Followers: XXXXXX [#](/creator/twitter::811036897883492352/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::811036897883492352/c:line/m:followers.svg)

- X Week XXXXXX +1.60%
- X Month XXXXXX +3.40%
- X Months XXXXXX +9.50%
- X Year XXXXXX +19%

### CreatorRank: XXXXXXX [#](/creator/twitter::811036897883492352/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::811036897883492352/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::811036897883492352/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXXX% [finance](/list/finance)  XXX% [cryptocurrencies](/list/cryptocurrencies)  XXXX% [exchanges](/list/exchanges)  XXXX% [technology brands](/list/technology-brands)  XXXX% [countries](/list/countries)  XXXX%

**Social topic influence**
[$dmac](/topic/$dmac) #1, [events](/topic/events) #1656, [$anab](/topic/$anab) #1, [$lly](/topic/$lly) 2.68%, [$kalv](/topic/$kalv) #1, [$lrmr](/topic/$lrmr) #1, [$arct](/topic/$arct) #1, [$acrs](/topic/$acrs) 2.3%, [approved](/topic/approved) #296, [$repl](/topic/$repl) #4

**Top accounts mentioned or mentioned by**
[@domvacchiano](/creator/undefined) [@biostocks](/creator/undefined) [@marketwirenews](/creator/undefined) [@esc](/creator/undefined) [@bowtiedbiotech](/creator/undefined) [@aacr](/creator/undefined) [@beachdudeca](/creator/undefined) [@chatdkg](/creator/undefined) [@era](/creator/undefined) [@endo](/creator/undefined) [@seed](/creator/undefined) [@ats](/creator/undefined) [@ecfs](/creator/undefined) [@ascp](/creator/undefined) [@pharmdca](/creator/undefined) [@thegunnerab](/creator/undefined) [@duedoctor](/creator/undefined) [@parasbiotech](/creator/undefined) [@andreagtc](/creator/undefined) [@jacobplieth](/creator/undefined)

**Top assets mentioned**
[Eli Lilly and Company (LLY)](/topic/$lly) [ArbitrageCT (ARCT)](/topic/$arct) [Rhythm Pharmaceuticals, Inc. Common Stock (RYTM)](/topic/$rytm) [GSK plc (GSK)](/topic/$gsk) [MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx) [Bitcoin Incognito (XBI)](/topic/$xbi) [Edgewise Therapeutics, Inc. Common Stock (EWTX)](/topic/$ewtx) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Apellis Pharmaceuticals, Inc. Common Stock (APLS)](/topic/$apls) [Crinetics Pharmaceuticals, Inc. (CRNX)](/topic/$crnx) [ATAI Life Sciences (ATAI)](/topic/$atai) [Taraxa (TARA)](/topic/$tara) [Arcellx, Inc. Common Stock (ACLX)](/topic/$aclx) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [PTC Therapeutics, Inc. (PTCT)](/topic/$ptct) [Roivant Sciences Ltd. Common Shares (ROIV)](/topic/$roiv) [Vir Biotechnology, Inc. Common Stock (VIR)](/topic/$vir) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX)](/topic/$rxrx) [SpringWorks Therapeutics, Inc. Common Stock (SWTX)](/topic/$swtx) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Jazz Pharmaceuticals, Inc. (JAZZ)](/topic/$jazz) [Hundred Million (100M)](/topic/$100m) [MEI Pharma, Inc. (MEIP)](/topic/$meip) [Arvinas, Inc (ARVN)](/topic/$arvn) [One Cash (ONC)](/topic/$onc) [Summit Therapeutics Inc. Common Stock (SMMT)](/topic/$smmt) [Alkermes Inc. plc (ALKS)](/topic/$alks) [Akropolis (AKRO)](/topic/$akro) [Neurocrine Biosciences, Inc. (NBIX)](/topic/$nbix) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Merck & Co., Inc. (MRK)](/topic/$mrk)
### Top Social Posts [#](/creator/twitter::811036897883492352/posts)
---
Top posts by engagements in the last XX hours

"🔔 Biotech Stock News 01/28 @ Open 🧬 📰 $NRXP XX% Funding Transaction for HOPE Clinic Acquisition $NBIX X% Ph3 Trial Initiation of Osavampator for Major Depression $ALLO X% IND Clearance for ALLO-329 $ACTI X% Patent for laquinimod in Eye Disorders $DRRX X% Publication of Larsucosterol Ph2b Study $HUMA X% Gene Editing Partnership with Pluristyx $AKRO X% Proposed Public Offering $ETNB X% Proposed Underwritten Public Offering $GOSS -X% Clinical & Preclinical Data at PVRI $AZN -X% US Approval for Breast Cancer Treatment $EPIX -X% Pricing of $5M Public Offering $LCTX -X% Second Tranche Closing of"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1884294356905115686) 2025-01-28 17:35:57 UTC 25.5K followers, 3572 engagements


"Biotech Stock Catalyst Watchlist 🚀 🎯 Ph2 & Ph3 readouts in Q2/H1 2025. $DMAC Phase X $ACRS Phase 2a $ARCT Phase X $INMB Phase X $KPTI Phase X $TARA Phase X $ROIV Phase X $EGRX Phase 2/3 $VIR Phase X $APLM Phase X $LLY Phase 2b $ANAB Phase X $BHVN Phase X $RXRX Phase X $VIRX Phase X $VIRX Phase X $SWTX Phase X $KZIA Phase X $SLS Phase 2a $AGEN Phase X $ACRS Phase X $CRDF Phase X $VRCA Phase X $NKTR Phase X $KAPA Phase X $CYBN Phase X $PROK Phase X $SPRO Phase X $CRDL Phase X $ATAI Phase X $INMB Phase X $ACIU Phase X $IMRX Phase 2a Check out the image for more details 📸"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1939393482742960240) 2025-06-29 18:40:13 UTC 25.6K followers, 32.8K engagements


"$ARCT ARCT-032 / Cystic Fibrosis / Phase X Safety findings No SAEs severe AEs or dose-limiting toxicities Dose-related increase in transient mild post-dose respiratory symptoms PK findings: Very low systemic exposure mRNA: all plasma specimens BLQ LNP lipid components sporadically detected in low concentrations (1.0 ng/mL) Prior results & Ph2 trial overview 📸 👇 2/7"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945258666174898389) 2025-07-15 23:06:21 UTC 25.6K followers, XXX engagements


"Biotech Stock Catalyst Watchlist 🚀 🎯 Ph2 & Ph3 readouts in Q2 2025 (1/2). $RVPH Phase X $VTGN Phase X $LLY Phase X $AGEN Phase X $GILD Phase X $IFRX Phase X $ALLO Phase X $HCM Phase X $PDSB Phase X $LLY Phase X $HCM Phase X $BCYC Phase 2/3 $PDSB Phase X $JAZZ Phase X $JAZZ Phase X $AAPG Phase X $CADL Phase X $KPTI Phase X $ACLX Phase X $DMAC Phase X $ACRS Phase 2a $CMPS Phase X $NKTR Phase 2b $KPTI Phase X $EWTX Phase X $EWTX Phase X $TARA Phase X $ROIV Phase X $XOMA Phase X $EGRX Phase 2/3 $VIR Phase X $APLM Phase X $PRAX Phase 2b $LLY Phase 2b $ANAB Phase X $BHVN Phase X $RXRX Phase 2"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1926707151835218050) 2025-05-25 18:29:16 UTC 25.6K followers, 31.6K engagements


"$IONS Donidalorsen / Hereditary angioedema / PDUFA Robust Data Supports Potential Preferred Treatment for HAE Prophylaxis Sustained Reduction in HAE attacks that continue to improve with extended treatment Prior trial results 📸 👇 3/7"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945258672378298524) 2025-07-15 23:06:23 UTC 25.6K followers, XXX engagements


"🧬 Weekly Biotech Moves 7/14/25 - 7/18/25 $XBI: -XXXX% ($86.27) 🔴 $IBB: -XXXX% ($129.73) 🔴"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1946342982334165050) 2025-07-18 22:55:02 UTC 25.6K followers, 3356 engagements


"📌 Biotech Stock News 7/18 @ Open 🔔 $TELO XX% Telomir-1 Update in Prostate Cancer $MEIP XX% $100M Private Placement $NKGN X% NKGen Biotech and Hekabio Partnership $OCGN X% 1st Patient Dosed in GARDian3 Trial $CTXR X% Closing of $9M Offering $LXRX X% Patient-reported Data @ ASPN'25 $ELDN X% Tegoprubart Updated Ph1b Data $ZVRA -X% MIPLYFFA & OLPRUVA Presentations $AMRX -X% CREXONT NDS in Canada $BMY -X% Reblozyl Topline Ph3 Results $SPRY -X% EURneffy Approved in UK $VTRS -X% MR-139 Ph3 Update $BCLI -XX% Nasdaq Delisting & OTCQB Transition See the image and comments for more details 📸👇"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1946241617092128946) 2025-07-18 16:12:15 UTC 25.6K followers, 4272 engagements


"📢 In case you missed it: Merck $MRK to Acquire Verona Pharma $VRNA 💸 Total transaction value $10B ($107 per ADS) 🫁 Deal adds Ohtuvayre the first novel inhaled COPD treatment in XX years approved by FDA in June 2024 launched August 2024 with rapid U.S. uptake; also in trials for non-CF bronchiectasis ✅ Closing expected Q4 2025 See image for more info 👇 📸"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1943337784171008459) 2025-07-10 15:53:27 UTC 25.6K followers, 7241 engagements


"Eye Disease Biotech Catalyst Watchlist 👁 20+ catalyst events happening this year 🚀 $UBX Phase 2b $OCUL Phase X $ADVM Phase X $LCTX Phase 1/2a $RGNX Phase X $EYPT Phase X $GKOS PDUFA $AERI Phase X $ALDX NDA Check out the picture for more details 📸"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1706301747092709540) 2023-09-25 13:36:52 UTC 25.5K followers, 4211 engagements


"📣 Biotech Stock News 06/30 @ Midday 🧬 📰 $PSTV XX% FDA Agreement for Dose Optimization Trial $BFRI XX% Major Restructuring Backed By Investment $IMNN X% Submits Compliance Plan for Listing $ASMB X% Doses First Participant in Phase 1b $SAVA X% Presented Preclinical Simufilam Data $CELC X% Clinical Data from Early Phase Studies $OSTX X% Positive 1-Year Survival Data Updates $TRAW X% Advances Antiviral Pipeline $MRNA X% Positive Phase X Results for Vaccine $CLNN X% Regulatory Update on Biomarker Analysis $TYRA X% Doses First Patient in Phase X Study $AUPH X% Positive Results from Phase X Study"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1939711525960495450) 2025-06-30 15:44:00 UTC 25.5K followers, 5369 engagements


"📌 Biotech Stock News 7/11 @ Open $CVM XX% Partnership for Multikine in Cancer $DARE X% Receives $6M Grant for Drug Delivery $MIRA X% SKNY-1 Results Update $NKGN X% 1st Dose of Troculeucel Administered $BBIO X% Business Combination Update $IKNA -X% ISS and Glass Lewis Recommend Merger $VALN -X% IXCHIQ EMA Restriction Lifted $CAPR -XX% Deramiocel BLA Regulatory Update $MIST -XX% Pricing of $52.5M & CRL Acceptance See the image and comments for more details 📸👇"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1943715259401007353) 2025-07-11 16:53:24 UTC 25.5K followers, 4565 engagements


"📢 M&A News: Buying Spree Continues for Concentra Acquires CARGO Therapeutics for $4.379/share in Cash + CVR 🧾 CVR entitles holders to: XXX% of net cash exceeding $217.5M at closing XX% of net proceeds from any asset sales within X years post-closing ✅ $CRGX board unanimously approved; insiders holding XXXX% of shares signed support agreements 📅 Tender offer expected by July XX 2025; deal closing targeted for August 2025 See image for more information 👇"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1942591713211781419) 2025-07-08 14:28:50 UTC 25.6K followers, 6416 engagements


"🔔 Opaleye Management Q1 25* Holdings Released. 🐳 Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: -XXXXX% 🚀 Top Holdings: $HROW $ETON $SNWV $LQDA $RYTM $CDXS $IMNM $TGTX $ARVN $OCUL $EWTX $TARA $DNA $GOSS $ANIK $PTGX $XOMA $TRVI $PVLA $GOSS *Holdings as of 3/31/25 in SEC form 13F **Change in value of public company shares held See image for more details 📸👇"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1923141090061976045) 2025-05-15 22:19:00 UTC 25.6K followers, 13.1K engagements


"🧬 Biotech Weekly News 7/7/25 - 7/11/25 Major Movers 📈 📉 $PROK XXX% Topline Data Ph2 REGEN-007 Trial $RYTM XX% Topline Results from Ph2 Trial $KALV XX% FDA Approves EKTERLY (sebetralstat) $ONCY XX% Highlights Pelareorep Survival Data $COGT XX% Topline Results SUMMIT Trial $JSPR -XX% Clinical Data Update on Briquilimab $MREO -XX% UX143 Phase X Study Final Analysis $CAPR -XX% Deramiocel BLA Regulatory Update $APGE -XX% 16-Week Data from Ph2 Trial $AGEN -XX% Two-Year Survival Data in CRC See image below. 📸 Check out @doepke_michel's post for details on topline data from $PROK Phase 2"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1943791742282817904) 2025-07-11 21:57:19 UTC 25.6K followers, 6933 engagements


"🔔 RA Capital Q1 25* Holdings Released. 🐳 Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: -XXXXX% 🚀 Top Holdings: $ASND $PCVX $RYTM $JANX $NAMS $ACLX $EWTX $RNA $WVE $ETNB $SPRY $SION $LENZ $DYN $TYRA $MLYS $GERN $RXST $BCAX $IRON *Holdings as of 3/31/25 in SEC form 13F **Change in value of public company shares held See image for more details 📸 👇"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1923129186195210246) 2025-05-15 21:31:42 UTC 25.6K followers, 17.2K engagements


"🤔 How many of the XX biopharma hedge funds have positions in any of the tickers mentioned above Based on Q1 XX HF data 📊 $NRIX 8/34 🔥 $ACRS 7/34 🔥 $SRPT 7/34 🔥 $VRNA 7/34 🔥 $BEAM 6/34 🔥 Access our FREE screener to check your fave stocks 👇"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1946699938525860338) 2025-07-19 22:33:27 UTC 25.6K followers, 2006 engagements


"🚨 X AdCom This Week 📣 $GSK ➯ Blenrep combinations (BVd & BPd) AdCom: July XX 2025 📅 Indication: Multiple myeloma BLA 761440 Plus X more July PDUFAs ahead Catch the full rundown in our last post 👇"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1944859330135908829) 2025-07-14 20:39:32 UTC 25.5K followers, 13.4K engagements


"🧬 Biotech Weekly News 04/21/25 - 04/25/25 Major Movers 📈 📉 $RZLT XX% Positive Recommendation Ph3 sunRIZE Study $SMMT XX% Ivonescimab Shows Superiority in NSCLC $HCM XX% Completed Enrollment Ph2 Registrational Study $TLSA XX% Initiated Dosing Ph2 Intranasal Foralumab Trial $BCAX XX% Updated Data from Phase 1/1b Trial $COEP -XX% Announced Merger Agreement $INTS -XX% $2.35M Public Offering $VYNE -XX% Update on VYN202 Program $IBIO -XX% Licensing of Antibody from AstralBio $BCTX -XX% Pricing of $13.8M Offering $4.50/share See image below. 📸 👇"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1915897685028311510) 2025-04-25 22:36:18 UTC 25.6K followers, 6412 engagements


"📡 July Biotech PDUFA Pulse: Whats on the FDA Radar 🔍 $REGN: Lynozyfic - Approved ✅ $RHHBY: Columvi + GemOx $REPL: RP1 + Opdivo (nivolumab) $GSK: Blenrep combinations (BVd & BPd) $ASND: TransCon hGH $APLS: EMPAVELI (pegcetacoplan) $PTCT: Sephience (sepiapterin) $REGN: Odronextamab $KALV: Sebetralstat - Approved ✅ Check out the July PDUFA calendar. 📅👇"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1942310016897122648) 2025-07-07 19:49:29 UTC 25.6K followers, 30.4K engagements


"Biotech Stock Catalyst Watchlist 🚀 🎯 Ph2 & Ph3 readouts in Q2 2025 (1/2). $GILD Phase X $ALLO Phase X $HCM Phase X $PDSB Phase X $LLY Phase X $HCM Phase X $BCYC Phase 2/3 $PDSB Phase X $JAZZ Phase X $JAZZ Phase X $AAPG Phase X $IMNN Phase X $CADL Phase X $ANAB Phase 2b $ALKS Phase X $PCRX Phase X $KPTI Phase X $ACLX Phase X $OSTX Phase X $DMAC Phase X $ACRS Phase 2a $SRRK Phase X $CMPS Phase X $NKTR Phase 2b $KPTI Phase X $EWTX Phase X $EWTX Phase X $TARA Phase X $ROIV Phase X $EGRX Phase 2/3 $VIR Phase X $APLM Phase X $LLY Phase 2b $ANAB Phase X $BHVN Phase X $RXRX Phase X $VIRX Phase 2"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1929249038509261037) 2025-06-01 18:49:49 UTC 25.6K followers, 26.1K engagements


"📌 Biotech Stock News 07/03 @ Open🧬 📰 $LIXT XX% Closing of $5M Placement $THTX XX% Acquired by CB Biotechnology $CLRB X% Closing of $6.9M Offering $OSTX X% End of Phase X Meeting Granted $VRTX X% Present Longer-Term Data on CASGEVY at EHA $ELAN X% Global Licensing Agreement for NUZ-001 Commercialisation $OGEN -X% Completes $16.5M Offering $NVS -X% Update on Ph3 GCAptAIN Study $FDMT -X% Accelerated 4D-150 Ph3 Development $DYN -X% Closing of Public Offering $NKTR -X% Closing of $115M Offering $IMAB -X% Positive Givastomig Ph1b Data $BCAB -X% Data from BA3182 Dose Escalation $INO -XX% Pricing"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1940799830961602886) 2025-07-03 15:48:32 UTC 25.5K followers, 2971 engagements


"🧬 Weekly Biotech Moves 6/23/25 - 6/27/25 $XBI: XXXX% ($83.01) 🟢 $IBB: XXXX% ($126.47) 🟢 See image below. 📸👇"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1938739925207441530) 2025-06-27 23:23:12 UTC 25.6K followers, 4342 engagements


"Don't miss out on future PDUFAs & AdComs 🎯 🗓 PDUFA events: groundbreaking stock milestones ✨ often trigger major stock movements 📈 ideal for trading & options strategies 💸 Access our free PDUFA Report to see more info 👇"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1942310019388551380) 2025-07-07 19:49:29 UTC 25.6K followers, 7988 engagements


"Breast Cancer Catalyst Watchlist🔬 Exciting catalyst events happening this year📅 $SYRS Ph2 $ATNX Ph2 $PBYI Ph2 $IMGN Ph1 $IMV Ph1b $AMAM Ph2/3 $PRLD Ph1 Even more catalyst events this year. $NXTC $ARVN $CRDF $ADAP Check out the image for more details📸"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1668629738242596868) 2023-06-13 14:41:45 UTC 25.6K followers, 3890 engagements


"Biotech Stock Catalyst Watchlist 🚀 🎯 Ph2 & Ph3 readouts in Q3 2025. $NAMS Phase 2a $CRDF Phase X $IXHL Phase X $ENTX Phase X $MLTX Phase X $LRMR Phase X $KAPA Phase X $RAPP Phase 2a $PMVP Phase X $ATAI Phase 2b $ARCT Phase X $CLNN Phase X $AMLX Phase X $PRAX Phase 2b $ANAB Phase X $BINV Phase 2a $VYNE Phase 2b $PCSA Phase X $LSTA Phase 2a $BINV Phase 2a $LLY Phase X $ATAI Phase 2b $GRI Phase 2a $FDMT Phase X $HRMY Phase X $IONS Phase X $ENTA Phase X $KALA Phase 2b $LTRN Phase X $INBX Phase X $BTAI Phase X $PRAX Phase X $ATYR Phase X $FBIO Phase X $UPB Phase X $INMB Phase X $IFRX Phase 2a"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1947036716457754997) 2025-07-20 20:51:42 UTC 25.6K followers, 24.5K engagements


"Learn how to build a simple stock screener with Python in under XX min 🧑💻 📈 📉 Checkout thread from @DomVacchiano 👇"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1942983834724896899) 2025-07-09 16:26:59 UTC 25.6K followers, XX engagements


"🧬 Biopharma Weekly Recap 📝 Interesting posts/ppl to check out 👇 @BowTiedBiotech 1/ 🫁 Mercks $10B Verona Bet: A Biotech Thread @Andre_AGTC $VRNA aquisition has positive effect on bios which are potential BO candidates $MDGL $MIRM $BBIO $SRRK $CRNX @JacobPlieth $VRNAs Enfisentirine Composition Patent Expired in 2020 Not a Concern for $MRK @LifeSciVC $MRK will acquire Verona Pharma $VRNA for $10B. Fun bit of biotech history. @A_May_MD Parallels Between $NKTR and $VRNA: Early-Stage Setup Market Potential and Sentiment Dynamics @doepke_michel $MDGL Positioned as Potential Takeover Target"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1944102553324863581) 2025-07-12 18:32:23 UTC 25.5K followers, 13.9K engagements


"📌 Biotech Stock News 7/7 @ Open 🧬 📰 $COGT XX% Topline Results from SUMMIT Trial $KALV XX% FDA Approves First Oral Treatment for Hereditary Angioedema $FBIO X% Granted Orphan Drug Designation for CAR T-cells $COLL X% $150M Share Repurchase Program $LXEO X% Breakthrough Therapy Designation for LX2006 $ALUR X% Submission of PMA and Study Analyses $URGN X% Completion of Ph3 UTOPIA Trial $ALC X% Acquires LumiThera and Asset for Wet AMD Treatment $BSX X% FDA Approval for Expanded Labeling $NTRA -X% Data on Tissue-Free MRD Assay $DNLI -X% FDA Acceptance and Priority Review for BLA $NRIX -2%"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1942253838402289849) 2025-07-07 16:06:15 UTC 25.5K followers, 3429 engagements


"$ONC FDA approves tablet formulation of BRUKINSA (zanubrutinib) for all X approved indications 💊 New tablets reduce pill burden & simplify dosing without compromising efficacy or safety ✅ Proven bioequivalent to capsules via Phase X crossover studies 🔄 Only BTK inhibitor offering flexible once or twice daily dosing 🩺 Only BTK inhibitor with recommended dosing for severe hepatic impairment BRUKINSA leads new CLL patient starts & is now top BTK inhibitor by U.S. market share See image for more details 👇"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1933248489976418379) 2025-06-12 19:42:12 UTC 25.6K followers, 2535 engagements


"July PDUFA Approval Decision Calendar Approval decisions for: $REGN $RHHBY $REPL $ASND $APLS $PTCT $KALV See details in our PDUFA calendar 📅 👉"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1939694731447202150) 2025-06-30 14:37:16 UTC 25.6K followers, 18.9K engagements


"📌 Biotech Stock News 07/16 @ Open 🧬 📰 $CGTX XX% Clinical Data from Ph2 Study $ONCY X% Aggregated Data on Pelareorep Effectiveness $CUE X% Complete Response Data in Ph1 Trial $RPTX X% Licensing Agreement for Lunresertib $VYGR X% Adds Fourth Alzheimer's Program to Pipeline $ADIL X% Regains Compliance with Nasdaq $KALV X% UK Approval of HAE Treatment $OGEN X% Manufacturing Agreement for ONP-002 Development $TMO -X% Strategic Partnership for Drug Manufacturing $BCDA -X% Patient Enrollment for CardiAMP HF Study $ENSC -X% Initiates Ph3 Study of PF614 $QNCX -X% Completes Enrollment in Phase 3"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945517869774848275) 2025-07-16 16:16:20 UTC 25.6K followers, 2495 engagements


"Biotech Stock Catalyst Watchlist 🚀 🎯 Ph2 & Ph3 readouts in Q3 2025. $PHVS Phase X $PHVS Phase X $NAMS Phase 2a $CGTX Phase X $DMAC Phase X $COGT Phase X $ENTX Phase X $MLTX Phase X $LRMR Phase X $RAPP Phase 2a $PMVP Phase X $ATAI Phase 2b $ARCT Phase X $CLNN Phase X $AMLX Phase X $PRAX Phase 2b $ANAB Phase X $BINV Phase 2a $VYNE Phase 2b $PCSA Phase X $LSTA Phase 2a $BINV Phase 2a $APGE Phase X $INMB Phase X $LLY Phase X $ATAI Phase 2b $GRI Phase 2a $FDMT Phase X $HRMY Phase X $IONS Phase X $ENTA Phase X $KALA Phase 2b $LTRN Phase X $INBX Phase X $BTAI Phase X $PRAX Phase X $ATYR Phase 3"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1941929261340016921) 2025-07-06 18:36:29 UTC 25.6K followers, 45.9K engagements


"🧬 Biotech Weekly News 7/14/25 - 7/18/25 Major Movers 📈 📉 $TELO XX% Telomir-1 Update in Prostate Cancer $KAPA XX% Positive Results from Ph2 Trial $MEIP XX% $100M Private Placement $DARE XX% Ovaprene Interim Ph3 Results $RCKT XX% Receives RMAT Designation for Gene Therapy $SRPT -XX% FDA Shipment Halt Warning for Elevidys $CLSD -XX% Explore Strategic Alternatives for SCS Platform $BCLI -XX% Nasdaq Delisting & OTCQB Transition $ABOS -XX% Strategic Collab. for Alzheimer's Therapy $IKNA -X% Stockholder Approval of Merger See image below. 📸 🚨 $SRPT closed down XX% after reports of 3rd gene"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1946342699277418706) 2025-07-18 22:53:55 UTC 25.6K followers, 7094 engagements


"📣 Biotech Stock News 07/02 @ Midday 🧬 📰 $LIXT XX% $5M Private Placement Announced $EYEN XX% Rebranding and Name Change $TIL XX% FDA Clearance for Phase X Trial $ABEO X% Closes Sale of Priority Review Voucher $CERS X% INTERCEPT Red Blood Cell CE Mark Update $CHRO X% Completes Merger and Private Placement $PROK X% Completes Domestication to Delaware $IVVD X% Study Group for Monoclonal Antibody Therapy $BLTE X% Completion of Enrollment in PHOENIX Trial $REGN X% FDA Accelerated Approval for Myeloma $ACOG X% Positive Pre-Clinical Data for ALPHA-1062 $MRK X% FDA Grants Priority Review for Label"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1940440127513518583) 2025-07-02 15:59:12 UTC 25.5K followers, 5310 engagements


"Check out our catalyst calendar 👇 & stay on top of key biopharma readouts 📅 🚀 $XBI $IBB"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1943792156818456756) 2025-07-11 21:58:58 UTC 25.6K followers, 1241 engagements


"Prostate Cancer Biotech Catalyst Watchlist🔬 Some big catalyst events happening this year👇 $FMTX Ph1 $ARVN Ph1 $MRUS Ph1/2 $RCUS Ph1b/2 $ORIC Ph1b $LLY Ph3 $BTAI Ph2b $LNTH Ph3 And even more events coming.👀 $HOOK $MGNX $CADL $EXEL $FUSN"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1662091017556836352) 2023-05-26 13:39:13 UTC 25.6K followers, 4055 engagements


"🧬 Weekly Biotech Moves 7/7/25 - 7/11/25 $XBI: XXXX% ($87.02) 🟢 $IBB: XXXX% ($131.59) 🟢"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1943792153345634443) 2025-07-11 21:58:57 UTC 25.6K followers, 2426 engagements


"📢 M&A News: Theratechnologies $THTX Acquired by CB Biotechnology for up to $254M 🤝 💵 $3.01/sh in cash + up to $1.19/sh CVR 📈 $THTX up XX% at open 🗓 Expected to close during the Companys Q4 ending November XX 2025. See more information 👇 📸"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1940783121408184781) 2025-07-03 14:42:08 UTC 25.5K followers, 10.8K engagements


"1/ 🚨 $GSK AdCom is tomorrow 7/17 🧵 💊 Belantamab mafodotin for r/r multiple myeloma ⚠ Ahead of meeting FDA raised safety concerns: 👇 🚩 High rates of ocular toxicity incl. corneal damage & vision loss In DREAMM-7 & DREAMM-8: 🔸 XX% of patients had eye toxicity (KVA events) 🔸 7778% had Grade XX events 🔸 70%+ had recurrent eye issues 🔸 XX% still had unresolved eye toxicity at cutoff 🔸 7678% needed dose mods due to eye toxicity 🚩 Dosing under fire: 🔸 High toxicity despite adjusted regimens (2.5 mg/kg vs. XXX mg/kg) 🔸 XX% remained on intended dose by Cycle X 🔸 Limited dose optimization"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945611449659007077) 2025-07-16 22:28:11 UTC 25.6K followers, 12K engagements


"Check out our catalyst calendar 👇 & stay on top of key biopharma readouts 📅 🚀 $XBI $IBB"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1942983837564440881) 2025-07-09 16:27:00 UTC 25.6K followers, 1344 engagements


"Biotech Stock Catalyst Watchlist 🚀 🎯 Ph2 & Ph3 readouts in Q3 2025. $NAMS Phase 2a $CGTX Phase X $CRDF Phase X $DMAC Phase X $IXHL Phase X $ENTX Phase X $MLTX Phase X $LRMR Phase X $RAPP Phase 2a $PMVP Phase X $ATAI Phase 2b $ARCT Phase X $CLNN Phase X $AMLX Phase X $PRAX Phase 2b $ANAB Phase X $BINV Phase 2a $VYNE Phase 2b $PCSA Phase X $LSTA Phase 2a $BINV Phase 2a $INMB Phase X $LLY Phase X $ATAI Phase 2b $GRI Phase 2a $FDMT Phase X $HRMY Phase X $IONS Phase X $ENTA Phase X $KALA Phase 2b $LTRN Phase X $INBX Phase X $BTAI Phase X $PRAX Phase X $ATYR Phase X $FBIO Phase X $UPB Phase 2"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1944458773806149859) 2025-07-13 18:07:52 UTC 25.6K followers, 33.1K engagements


"$FBIO ✔ CUTX-101 (Copper Histidinate) / Menkes Disease / PDUFA Showed significant clinical benefit in both CuHis-ET (early tx) and CuHis-LT (late tx) cohorts 75-79% reduction in risk of death compared to untreated Historical Control (HC-ET and HC-LT) arms increase in Median OS from XXX years to XXXX years in the ET cohort Prior results 📸 👇 4/7"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945258677990252701) 2025-07-15 23:06:24 UTC 25.5K followers, XXX engagements


"Each quarter we identify major catalyst events 🥳 Likely to move the stock +/- by XX% 📈 📉 $MLTX Sonelokimab $LRMR Nomlabofusp (CTI-1601) $IFRX INF904 Access our FREE Big Mover Report 👇"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1947036720882713048) 2025-07-20 20:51:43 UTC 25.6K followers, XXX engagements


"🔔 Baker Bros. Q1 25* Holdings Released. 🐳 Holdings: XX Holdings in Top 20: XXXXX% Qtr over Qtr Change**: -XXXX% 🚀 Top Holdings: $ONC $INCY $ACAD $MDGL $SMMT $INSM $RYTM $RVMD $KYMR $ALKS $EWTX $REPL $INSM $IMVT $BCYC $IMCR $KNSA $ABCL $RARE $DNLI *Holdings as of 3/31/25 in SEC form 13F **Change in value of public company shares held See image for more details 📸👇"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1923137621208997937) 2025-05-15 22:05:13 UTC 25.5K followers, 20.4K engagements


"6 Stocks Likely to Move Big on Rare/Genetic Disease Readouts in Q3 XX 📈 📉 See 🧵 for more details about each asset/readout 👇 $ARCT (Mid-2025) ARCT-032 / Cystic Fibrosis / Phase X $IONS (August XX 2025) Donidalorsen / Hereditary angioedema / PDUFA $FBIO (September XX 2025) ✔ CUTX-101 (Copper Histidinate) / Menkes Disease / PDUFA $KALA (Q3 2025) KPI-012 / Persistent Corneal Epithelial Defect / Phase 2b $HRMY (Q3 2025) Zygel (ZYN002 CBD Gel) / Fragile X syndrome / Phase X $LRMR (September 2025) ✔ Nomlabofusp (CTI-1601) / Friedreichs Ataxia / Phase X ✔ = Expected big stock move confirmed by"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945258659799556112) 2025-07-15 23:06:20 UTC 25.6K followers, 5919 engagements


"Let's see how many of the XX biopharma-focused hedge funds hold these tickers (5 is 🔥). $MLTX 7/34 🔥 $LRMR 4/34 $IFRX 1/34 Access our FREE hedge fund screener & search your fav tickers 👇"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1947036722971451839) 2025-07-20 20:51:43 UTC 25.6K followers, XXX engagements


"Each quarter we identify major catalyst events 🥳 Likely to move the stock XX% or more 📈 📉 $KZIA Paxalisib Ph2/3 $ATAI RL-007 Ph2b $CRNX Paltusotine PDUFA $INMB INKmune Ph2 and more 🚀 Access our FREE Big Mover Report 👇"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1946343944239059319) 2025-07-18 22:58:52 UTC 25.6K followers, 1596 engagements


"Biotech Stock Catalyst Watchlist 🚀 🎯 Ph2 & Ph3 readouts in Q2/H1 2025. $OSTX Phase X $DMAC Phase X $ACRS Phase 2a $CMPS Phase X $NKTR Phase 2b $KPTI Phase X $EWTX Phase X $EWTX Phase X $TARA Phase X $ROIV Phase X $EGRX Phase 2/3 $VIR Phase X $APLM Phase X $LLY Phase 2b $ANAB Phase X $BHVN Phase X $RXRX Phase X $VIRX Phase X $VIRX Phase X $SWTX Phase X $KZIA Phase X $SLS Phase 2a $NUVL Phase X $AGEN Phase X $ACRS Phase X $CRDF Phase X $VRCA Phase X $NKTR Phase X $KAPA Phase X $CYBN Phase X $ARCT Phase X $PROK Phase X $ANRO Phase X $SPRO Phase X $INMB Phase X $CRDL Phase X $ATAI Phase X $INMB"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1936859643827098049) 2025-06-22 18:51:38 UTC 25.5K followers, 20.6K engagements


"📣 Biotech Stock News 07/17 @ Open $SRPT XX% Strategic Restructuring & Pipeline Update $RCKT XX% Receives RMAT Designation for Gene Therapy $MBRX XX% Explores Accelerated Strategic Partnerships $DMAC X% Positive Interim Phase X Results $MAIA X% Peer-Reviewed Pub. on Anticancer Prodrugs $AGEN X% FDA Approves SHINGRIX Prefilled Syringe $XXII X% Launch Confirms Viability of Nicotine Mandate $DNA X% Launches ADME Profiling Service $SDGR X% Expand Research Collaboration on JAK Target $PRAX X% FDA Breakthrough Therapy for Relutrigine $CYBN X% UK Approval for EMBRACE Study $NKGN X% New Funding for"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945871031148876231) 2025-07-17 15:39:41 UTC 25.6K followers, 9202 engagements


"1/ 🚨 PDUFA Pulse: 🔍 Whats on the FDA Radar This July 👀 $REGN: Lynozyfic Approved ✅ $RHHBY: Columvi + GemOx $REPL: RP1 + Opdivo (nivolumab) $GSK: Blenrep combinations (BVd & BPd) $ASND: TransCon hGH $APLS: EMPAVELI (pegcetacoplan) $PTCT: Sephience (sepiapterin) $REGN: Odronextamab $KALV: Sebetralstat Check out the July PDUFA calendar. 📅👇 💡 Cantor initiates coverage on $REPL ahead of July XX PDUFA full context below from @Quantumup1"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1940499624751734957) 2025-07-02 19:55:37 UTC 25.6K followers, 21.5K engagements


"$GSK 📣 FDAs ODAC votes against belantamab mafodotin combos in R/R multiple myeloma ❌ XX vote against BVd (with bortezomib) 👎👎👎👎👎 vs. 👍👍👍 ❌ XX vote against BPd (with pomalidomide) 👎👎👎👎👎👎👎 vs. 👍 ⚠ Reason: High ocular toxicity & poor tolerability despite PFS gains in DREAMM-7/8 FDA questioned dosage selection & real-world relevance of trial data Committee urged exploration of lower more tolerable doses 📉 A tough call: Strong efficacy but stronger toxicity concerns"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945960037979242732) 2025-07-17 21:33:21 UTC 25.6K followers, 5222 engagements


"Biotech Stock Catalyst Watchlist 🚀 🎯 Ph2 & Ph3 readouts in Q2 2025. $OSTX Phase X $DMAC Phase X $ACRS Phase 2a $SRRK Phase X $CMPS Phase X $NKTR Phase 2b $KPTI Phase X $EWTX Phase X $EWTX Phase X $TARA Phase X $ROIV Phase X $EGRX Phase 2/3 $VIR Phase X $APLM Phase X $LLY Phase 2b $ANAB Phase X $BHVN Phase X $RXRX Phase X $VIRX Phase X $VIRX Phase X $SWTX Phase X $KZIA Phase X $SLS Phase 2a $NUVL Phase X $AGEN Phase X $ACRS Phase X $CRDF Phase X $VRCA Phase X $NKTR Phase X $KAPA Phase X $CYBN Phase X $MLYS Phase X $ARCT Phase X $PROK Phase X $ANRO Phase X $SPRO Phase X $VTYX Phase 2a $MURA"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1934311965901635605) 2025-06-15 18:08:05 UTC 25.5K followers, 27.3K engagements


"$LRMR ✔ Nomlabofusp (CTI-1601) / Friedreichs Ataxia / Phase X Generally well tolerated Dose dependent increases of frataxin levels in tissues tested (skin and buccal cells) FXN levels increased to XX% to XX% of the average of the healthy volunteers after OD x XX days dosing Prior results 📸 👇 7/7"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945258697317605760) 2025-07-15 23:06:29 UTC 25.6K followers, 2032 engagements


"$GSK $AGEN 💉 FDA approves GSKs SHINGRIX in a prefilled syringe Simplifies administration no vial reconstitution needed 👍 Based on data showing technical comparability to current 2-vial version Supports easier delivery for healthcare professionals 💯 1M people develop shingles in the US annually"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945892628165476838) 2025-07-17 17:05:30 UTC 25.6K followers, 3687 engagements


"Each quarter we identify major catalyst events 🥳 Likely to move the stock +/- by XX% 📈 📉 Prev. Qtr Movers: 🟢 $LYRA XXXXXX% 🟢 $NKTR XXXXXX% 🔴 $IFRX -XXXXX% 🔴 $PRTA -XXXXX% Access our free Big Mover Report 👇"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945258700966408234) 2025-07-15 23:06:30 UTC 25.6K followers, 2154 engagements


"Each quarter we identify major catalyst events 🥳 Likely to move the stock XX% or more 📈 📉 $KZIA Paxalisib Ph2/3 $ATAI RL-007 Ph2b $CRNX Paltusotine PDUFA and more 🚀 Access our FREE Big Mover Report 👇"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1941196214466380236) 2025-07-04 18:03:37 UTC 25.6K followers, 1626 engagements


"📌 Biotech Stock News 7/14 @ Open $DARE XX% Ovaprene Interim Phase X Results $RANI XX% Bioequivalence of Novel Oral Agonist $EPIX X% Acquired by Xenotherapeutics $AMLX X% New Analyses from Ph2 Trials $CRNX X% New Long-Term Data on Paltusotine $VSTM X% Publication of Ph2 RAMP XXX Results $GILD X% New Data on Lenacapavir for HIV $RYTM X% Data on MC4R Agonists at ENDO 2025 $NBIX X% One-Year Data on CRENESSITY Efficacy $RARE X% Approval Extended for HoFH Treatment $RARE X% CRL for UX111 AAV Gene Therapy $PHGE X% Ph2b Trial for BX004 Initiated $CORT X% NDA for Relacorilant $CELC X% New Patent for"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1944795798333755837) 2025-07-14 16:27:05 UTC 25.5K followers, 3764 engagements


"📣 Biotech Stock News 07/15 @ Open 🧬 📰 $KAPA XX% Positive Safety Results from Phase X Trial $PROK X% Alignment with FDA on Approval Pathway $LSTA X% Expands Intellectual Property Portfolio $CTXR X% Expands Distribution Network for LYMPHIR $CVM X% Closing of $XXX Million Offering $SLS X% Meets Primary Endpoints in Phase X Trial $ADAG X% Regulatory Update on Clinical Development $ATRA X% Transfer of Investigational New Drug Application $AEMD X% Positive Data Review for Next Trial $AQST X% International Expansion Update for Anaphylm $PYPD -X% Long-Acting GLP-1 Delivery Platform $GH -X% First"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945152036066222141) 2025-07-15 16:02:39 UTC 25.6K followers, 4492 engagements


"🧬 Biopharma Weekly Recap 📝 Interesting posts/ppl to check out 👇 @ohadhammer New Jefferies Report Explores Chinas Biotech Ecosystem @BowTiedBiotech Great figure from Oppenheimer team on The China Trade  @BioStocks $MDGL Notice of Allowance from U.S. Patent and Trademark Office for New U.S. Patent Covering Rezdiffra. @seedy19tron Oral hearing for the $NKTR $LLY case @GeneInvesting REMEMBER $NTLA @yaireinhorn David Liu Warns of Impact from NIH Funding Cuts on U.S. Science @Prof_Oak_ $PRME proposing to reprice 8.3M options on the back of a 300%+ bounce from May lows @adamfeuerstein Leadership"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1946699121982943514) 2025-07-19 22:30:13 UTC 25.6K followers, 16K engagements


"$DMAC +7% 🟢 Reports positive interim Ph2 results in preeclampsia 🔬 DM199 showed strong BP reductions (systolic & diastolic cohorts 69) Check out our catalyst calendar 👇 & stay on top of key biopharma readouts 📅 🚀"  
![@BiopharmIQ Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::811036897883492352.png) [@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1945874275971559760) 2025-07-17 15:52:34 UTC 25.5K followers, 1359 engagements